Karen Bevers

Karen Bevers

Auto-generated profile, based on publicly available information

Karen Bevers

Department of Rheumatology, Sint Maartenskliniek, Nijmegen, The Netherlands

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

4 April 2014 in Rheumatology
Verified
Journal Article
Closed access
PDF file
KBKaren Bevers
Karen Bevers
JBJohannes W. Bijlsma
Johannes W. Bijlsma
JVJohanna E. Vriezekolk
Johanna E. Vriezekolk
CECornelia Helena van Den Ende
Cornelia Helena van Den Ende
ABAlfons Abigael Den Broeder
Alfons Abigael Den Broeder
Objective. Radiographic knee OA is moderately associated with pain. As OA is a disease of the entire joint, ultrasonography visualizing cartilage and soft tissue structures might provide more insight into the complex process of pain in knee OA. The objective of this study was to investigate the cross-sectional association between US findings and pain in knee OA.

31 August 2019 in BMC Musculoskeletal Disorders
Verified
Journal Article
Open access
PDF file
TPTim Pelle
Tim Pelle
KBKaren Bevers
Karen Bevers
JPJob van der Palen
Job van der Palen
FHFrank H. J. van Den Hoogen
Frank H. J. van Den Hoogen
CECornelia Van den Ende
Cornelia Van den Ende
This paper describes (the development of) an eHealth tool (dr. Bart app) to enhance self-management and to optimize non-surgical health care utilization in patients with knee and/or hip osteoarthritis (OA) and presents a study aiming 1) to study the effectiveness of the dr. Bart app on health care use 2) to explore differences in use, usability and the clinical outcomes of the dr. Bart app between the Netherlands and Germany. The dr. Bart app is a fully automated eHealth application and is based on the Fogg model for behavioural change, augmented with reminders, rewards and self-monitoring to reinforce app engagement and health behaviour. The dr. Bart app propose goals to a healthier lifestyle based on machine learning techniques fed by data collected in a personal profile and choosing behaviour of the app user. Patients ≥50 years with self-reported knee and/or hip OA will be eligible to participate. Participants will be recruited in the community through advertisements in local newspapers and campaigns on social media. This protocol presents a study with three arms, aiming to include 161 patients in each arm. In the Netherlands, patients are randomly allocated to usual care or dr. Bart app and in Germany all patients receive the dr. Bart app. The primary outcome of the first research question is the number of self-reported consultations in secondary health care. The primary outcome of the second research question (comparison between the Netherlands and Germany) is self-management behaviour assessed by the patient activation measure (PAM-13) questionnaire. Secondary outcomes are costs, health-related quality of life, physical functioning and activity, pain, use and usability of the dr. Bart app. Data will be collected through three online questionnaires (at baseline and after 3 and 6 months after inclusion). This study will gain insight into the effectiveness of the dr. Bart app in the (conservative) treatment of patients with knee and/or hip OA and differences in the use and usability of the dr. Bart app between the Netherlands and Germany. Dutch Trial Register (Trial Number NTR6693 / NL6505 ). Registration date: 4 September 2017.

23 June 2015 in Rheumatology
Verified
Journal Article
Open access
PDF file
KBKaren Bevers
Karen Bevers
JVJohanna E. Vriezekolk
Johanna E. Vriezekolk
JBJohannes W. J. Bijlsma
Johannes W. J. Bijlsma
CECornelia Van den Ende
Cornelia Van den Ende
ABAlfons A. Den Broeder
Alfons A. Den Broeder
Objective. The aim of this study was to investigate the association between a set of US features and radiographic and clinical progression of knee OA after 2 years of follow-up. Methods. A total of 125 patients fulfilling ACR clinical criteria for knee OA underwent US examination of the most symptomatic knee. The US protocol included assessment of synovial hypertrophy, joint effusion, infrapatellar bursitis, Baker’s cyst, medial meniscus protrusion and cartilage thickness. Clinical progression was defined using the inverse Osteoarthritis Research Society International responder criteria or progression to total knee replacement. Radiological progression was defined as a ≥2 point increase in Altman score or progression to total knee replacement. Regression analyses were performed with baseline ultrasonographic features as independent variables and progression (two separate models for clinical progression and radiographic progression) as the dependent variable. Results. A total of 31 (25%) patients fulfilled the criteria of clinical progression and 60 (48%) patients fulfilled the criteria of radiological progression. The presence of Baker’s cyst showed a statistically significant association with clinical [odds ratio (OR) 3.07 (95% CI 1.21, 7.78)] as well as radiological [OR 2.84 (95% CI 1.17, 6.90)] progression. Synovial hypertrophy showed a weaker but consistent association with clinical as well as radiological progression [OR 2.11 (95% CI 0.80, 5.57)]. Conclusion. We demonstrated a longitudinal association between Baker’s cyst (and to a lesser extent synovial hypertrophy) at baseline and radiological and clinical progression after 2 years.

1 October 2014 in Osteoarthritis and Cartilage
Verified
Journal Article
Closed access
KBK. Bevers
K. Bevers
JBJ.W.J. Bijlsma
J.W.J. Bijlsma
JVJ.E. Vriezekolk
J.E. Vriezekolk
CECornelia Van den Ende
Cornelia Van den Ende
ABA.A. Den Broeder
A.A. Den Broeder

17 October 2012
Verified
Journal Article
Closed access
KBKaren Bevers
Karen Bevers
MZManon C Zweers
Manon C Zweers
CECornelia H M Van Den Ende
Cornelia H M Van Den Ende
HMHenk A Martens
Henk A Martens
EMElien Mahler
Elien Mahler
ABAlfons A Den Broeder
Alfons A Den Broeder